About half of the people who take antidepressants do not respond -- and many patients experience adverse effects. These outcomes may be partially attributed to the impact of an individual’s genetic profile. Understanding the neurobiology of depression and using a pharmacogenomic decision-support tool, clinicians could provide personalized healthcare designed to improve antidepressant therapy outcomes. In this presentation, the evidence, evolution and current state of antidepressant pharmacogenetic decision support tools is reviewed. A series of considerations for clinicians contemplating use of these tools is presented in the context of contemporary NP practice.
Streaming Online Video:
Instant access! Place your order. Receive a welcome email and you're ready to go. No waiting!
View your videos. Complete your evaluation. Print your certificate. It's that easy!
To access videos:
- Log in to APEA CE Center or download APEA's free mobile app
- Download or stream your course videos and course manual
- Complete the quiz and evaluation and earn your credits!
*Please note: Videos require the Google Chrome browser.*
Written course material and evaluation MUST be accessed within 6 months after purchase.
After taking part in this educational activity, participants will be able to:
- Conceptualize mental illness in the context of epi/genetics and neurobiology, with an emphasis on depressive disorders.
- Discuss contemporary approaches to management of depressive disorders, including practical applications for nurse practitioners.
- Apply concepts of pharmacogenomics to the selection, prescription and management of drug therapy for disorders of depressed mood.
TIME TO COMPLETE
1 hours 30 minutes
Each video is accessible twice within six months of purchase.
NPACE designates this educational activity for a maximum of 1.00 CNE credit(s), of which 1.00 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
February 2021; Reviewed February 2022
Program ID: 20VCDEP
Provider Accreditation Statement
This program is provided by Nurse Practitioner Associates for Continuing Education (NPACE).
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
NPACE, the Provider of awarding contact hours, is responsible for adherence to ANCC criteria.
This course is taught by Josh Hamilton, DNP, RN-BC, FNP-C, PMHNP-BC, CNE, FAANP, The Hamilton Group LLC, President and Chief Clinical Officer. Josh Hamilton is an NP with more than 20 years of experience. He is nationally certified as a psychiatric-mental health nurse; family nurse practitioner; family psychiatric nurse practitioner and nurse educator. He is an AANP Fellow and a certified master clinical psychopharmacologist through the Neuroscience Education Institute. He speaks regularly around the country about new advancements in behavioral health and psychiatry. Josh Hamilton has disclosed no relevant financial relationships.
APEA Mobile is a free app for Apple and Android devices. Purchases must be made through apea.com and will automatically be synced to your app. Content downloaded to your device from the app can be accessed at any time, even without an internet connection.
Minimum space required: Each video section may take up to 150 MB. Each audio section may take up to 90 MB. Requires iPhone versions 5 and above and iPad Air and Mini and above.